EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RNA‐based medicine: from molecular mechanisms to therapy

Anke Sparmann iD, Jörg Vogel iD

The EMBO Journal · 02.11.2023 · 42 (21)

DOI: 10.15252/embj.2023114760 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The EMBO Journal, online erschienen am 20.09.2023. Verfasst von Anke Sparmann und 1 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany. Hauptthemen laut MEDLINE: RNA, Pandemics. Die Arbeit wurde bisher 147-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Elite Network Bavaria/Elitenetzwerk Bayern.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA‐based therapeutics have the potential to revolutionize the treatment and prevention of human diseases. While early research faced setbacks, it established the basis for breakthroughs in RNA‐based drug design that culminated in the extraordinarily fast development of mRNA vaccines to combat the COVID‐19 pandemic. We have now reached a pivotal moment where RNA medicines are poised to make a broad impact in the clinic. In this review, we present an overview of different RNA‐based strategies to generate novel therapeutics, including antisense and RNAi‐based mechanisms, mRNA‐based approaches, and CRISPR‐Cas‐mediated genome editing. Using three rare genetic diseases as examples, we highlight the opportunities, but also the challenges to wide‐ranging applications of this class of drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNAPandemicsHumansGene EditingRNA InterferenceGenetic Therapy

Stichwörter der Autor:innen

CRISPR-Cas therapyRNA interferenceantisense oligonucleotide drugmRNA therapeuticsrare genetic disease

Substanzen

RNA

Autor:innen und Institutionen

  • Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
  • Institute of Molecular Infection Biology (IMIB), University of Würzburg, Würzburg, Germany.

ORCID-Profile: Anke Sparmann, Jörg Vogel

Förderung

  • Elite Network Bavaria/Elitenetzwerk Bayern

Zitieren

APA

Sparmann, A., & Vogel, J. (2023). RNA‐based medicine: from molecular mechanisms to therapy. The EMBO Journal, 42(21). https://doi.org/10.15252/embj.2023114760

Vancouver

Sparmann A, Vogel J. RNA‐based medicine: from molecular mechanisms to therapy. The EMBO Journal. 2023;42(21). doi:10.15252/embj.2023114760

BibTeX
@article{Sparmann2023,
  author = {Sparmann, Anke and Vogel, Jörg},
  title = {RNA‐based medicine: from molecular mechanisms to therapy},
  journal = {The EMBO Journal},
  year = {2023},
  volume = {42},
  number = {21},
  doi = {10.15252/embj.2023114760}
}
Kostenlos starten →